The size of the trauma fixation devices market in Europe is predicted to worth USD 2.14 Billion by 2027 from USD 1.62 Billion in 2022, growing at a CAGR of 5.77% between 2022 to 2027.
Trauma is a medical condition caused by various strains or physical injuries, such as, dislocation, fractures, or burns, for which the trauma fixation devices are a prominent solution.
According to the statistics of 2015, there were 61 million people in the age group of 65 years and above, in Germany, the U.K., Italy, France, and Spain together. The ever-growing aging population in European countries is acting as a force for the growth of the trauma fixation devices market as the aged personnel has a high risk of osteoporosis leading to a rise in demand for trauma devices.
The factors driving the growth in Europe trauma fixation devices market are growing awareness about the latest products in the medical field, an increase in disposable incomes, supportive policies of governments, provision for reimbursements, ease of access to advanced medical facilities, rise in healthcare R&D expenditure, unaffordability of surgeries.
However, problems associated with the biocompatibility of the internal and external trauma devices and the high cost of advanced technologies are limiting the reach of the trauma fixation devices in this region.
This research report on the European Trauma Fixation Devices Market has been segmented and sub-segmented into the following categories:
By End Users:
Key market participants in the Europe Trauma Fixation Devices Market profiled in this report are Smith & Nephew, DePuy Synthesis, Stryker Corporation, Zimmer, Arthrex, Biomet, Conmed, Integra Lifesciences Corporation, Medtronic, Inc. and Bioretec, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com